30
Participants
Start Date
July 31, 2004
Study Completion Date
December 31, 2004
Abacavir sulfate
Abacavir sulfate, lamivudine, and zidovudine
Columbia IMPAACT CRS, New York
Bronx-Lebanon Hosp. IMPAACT CRS, The Bronx
Children's National Med. Ctr. Washington DC NICHD CRS, Washington D.C.
Children's National Med. Ctr., ACTU, Washington D.C.
UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases, Chapel Hill
Med. College of Georgia School of Medicine, Dept. of Peds., Div. of Infectious Diseases, Augusta
Univ. of Florida Jacksonville NICHD CRS, Jacksonville
USF - Tampa NICHD CRS, Tampa
St. Jude/UTHSC CRS, Memphis
Children's Hospital of Michigan NICHD CRS, Detroit
Chicago Children's CRS, Chicago
Tulane/LSU Maternal/Child CRS, New Orleans
Children's Hospital of Los Angeles NICHD CRS, Los Angeles
Usc La Nichd Crs, Alhambra
UCSD Mother-Child-Adolescent Program CRS, San Diego
HMS - Children's Hosp. Boston, Div. of Infectious Diseases, Boston
Baystate Health, Baystate Med. Ctr., Springfield
UMDNJ - Robert Wood Johnson Med. School, Div. of Allergy, Immunology & Infectious Diseases, New Brunswick
Rutgers - New Jersey Medical School CRS, Newark
San Juan City Hosp. PR NICHD CRS, San Juan
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH